why choose us

First received: August 17, 2023

Clinical Trial: Early Parkinson's Disease Monotherapy With CVN424

Study Status: Completed

Recruit Status: RECRUITING

Condition: Parkinson Disease

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled Trial of CVN424 in Early Parkinson's Disease

Brief Summary: This is a multicenter, 12-week, placebo-controlled clinical trial of CVN424 150 milligrams (mg) tablets in early, untreated Parkinson's Disease (PD).Participants will be randomized in a 1:1 ratio to CVN424 150 mg or placebo at the Baseline Visit.The purpose of this study is to measure effect on motor features with CVN424 compared to placebo in early, untreated Parkinson's Disease (PD) and to evaluate the potential of CVN424 to improve motor and non-motor functions in participants with early PD who are…

Read more